Phoebe Ashley, MD
Cardiovascular Disease (Cardiology) · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 12
- 2 carriers
- Offices
- 6
- Since medical school
- 32 years
- Graduated 1994
Offices
6 locations · UCSF Medical Group Business Services · Regents of the University of California · University of California San Francisco
Hospitals listed: UCSF Medical Center. That is not proof they admit you there this week.
Plans that list them
12 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Ashley’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
12 of 12 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence C180793 · Current
Licensed to practise in California · since 2022 · expires 2028-09-30 · Medical College of Wisconsin.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Cardiovascular Disease
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- UCSF Medical CenterSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of University of California Health, which runs 12 hospitalsHome of UCSF Helen Diller Family Comprehensive Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 81% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 4.9 (3.79 to 6.02) · 7,590 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 12.8 (11.3 to 14.4) · 2,019 cases, Jan 2024 – Dec 2024Better than the national rate — Death rate among surgical inpatients with serious treatable complications: 139.4 (110.22 to 168.58) · 452 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.622, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.626, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.491, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.8 (0.7 to 1) · 2,336 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for UCSF Medical Center
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 3 better, 5 the same, 3 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.9 (3.79 to 6.02) · 7,590 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.8 (11.3 to 14.4) · 2,019 cases | Worse | Jan 2024 – Dec 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 139.4 (110.22 to 168.58) · 452 cases | Better | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.622 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.626 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.491 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.7 to 1) · 2,336 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.24 (0.58 to 1.9) · 4,689 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.05 (0.89 to 1.2) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.9 · 89 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.5 · 85 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.1 · 132 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.6 · 454 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 618 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 380 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.7 · 5,000 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.22 (0.06 to 0.38) · 15,965 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.05 to 0.35) · 17,859 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.85 (0 to 1.83) · 4,184 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2 (1.1 to 2.9) · 6,516 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.35 (4.49 to 10.21) · 3,989 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5 (3.22 to 6.77) · 4,087 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.95 (0.74 to 3.15) · 2,034 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.95 (0.63 to 1.28) · 15,431 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 399 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.899 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.689 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.224 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16 · 156 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20 · 564 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 60.3 · 160 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -9.7 · 550 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 44.1 · 660 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 667 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (4.8 to 6.7) · 2,019 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6 · 421 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.5 · 53 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 107 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.9 (11.3 to 17.1) · 3,247 cases | No different | Jan 2022 – Dec 2024 |
What patients said (3,181 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 50% |
| "YES", patients would definitely recommend the hospital | 81% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$56,760
Medicare paid this office $56,760 for 282 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Long return visit (40+ min) | 161 | $23,293 | $111 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 26 | $7,457 | $105 |
| New patient visit (60+ min) | 44 | $6,263 | $142 |
| Return visit (30+ min) | 51 | $4,519 | $77 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 70 | $4,194 | $27 |
See all 11 services
| Long return visit (40+ min) | 161 | $23,293 | $111 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 26 | $7,457 | $105 |
| New patient visit (60+ min) | 44 | $6,263 | $142 |
| Return visit (30+ min) | 51 | $4,519 | $77 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 70 | $4,194 | $27 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 193 | $3,408 | $14 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 18 | $2,490 | $138 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $1,532 | $70 |
| New patient visit (45+ min) | 13 | $1,195 | $92 |
| Insertion of needle into vein for collection of blood sample | 19 | $251 | $9 |
| Online digital evaluation and management service for an established patient for up to 7 days, total time 5-10 minutes | 18 | $240 | $11 |
Who their Medicare patients are
282 Original Medicare patients in 2024. Average age 75 · Under 65 8% · 85 and older 12% · Women 53% · Also on Medicaid 35% · Health risk score 2.14. Above the middle of the specialty; the typical cardiology clinician is at 1.71.
Conditions among them: High blood pressure 75% · Coronary heart disease 61% · Heart failure 44% · Atrial fibrillation 41% · Diabetes 39% · Chronic kidney disease 36% · Depression 33% · Cancer 22% · COPD 21% · Stroke 15% · Dementia 9%.
The office billed $381,910, Medicare allowed $78,684 and paid $56,760; for 914 services of 21 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 282 | 914 | 75 | 2.14 | $381,910 | $56,760 |
| 2023 | 371 | 1,035 | 75 | 2.16 | $604,476 | $98,296 |
| 2022 | 515 | 834 | 73 | 2.00 | $249,228 | $41,541 |
| 2021 | 800 | 1,237 | 72 | 2.08 | $289,468 | $63,849 |
| 2020 | 894 | 1,278 | 71 | 2.58 | $294,076 | $61,574 |
| 2019 | 894 | 1,456 | 71 | 2.43 | $360,290 | $79,613 |
| 2018 | 910 | 1,462 | 70 | 2.55 | $341,800 | $72,197 |
| 2017 | 1,165 | 1,991 | 69 | 2.49 | $386,346 | $87,942 |
| 2016 | 1,193 | 2,093 | 69 | 2.51 | $356,617 | $85,263 |
| 2015 | 611 | 1,132 | 69 | 2.57 | $244,411 | $62,648 |
| 2014 | 275 | 649 | 72 | 1.86 | $114,220 | $30,278 |
| 2013 | 181 | 887 | 73 | 1.23 | $153,787 | $44,193 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 14 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 92 | $36,182 | $105 |
| Long return visit (40+ min) | 122 | $22,649 | $126 |
| New patient visit (60+ min) | 92 | $13,000 | $141 |
| Return visit (30+ min) | 64 | $6,316 | $80 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 36 | $4,069 | $70 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 35 | $4,024 | $115 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 24 | $3,690 | $154 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 50 | $2,564 | $28 |
| Hospital discharge day management, more than 30 minutes | 18 | $1,824 | $101 |
| New patient visit (45+ min) | 18 | $1,337 | $74 |
| Hospital discharge day management, 30 minutes or less | 11 | $802 | $73 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 17 | $286 | $17 |
| Insertion of needle into vein for collection of blood sample | 13 | $211 | $8 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 15 | $174 | $12 |
2022: 15 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 176 | $8,672 | $48 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 26 | $8,451 | $87 |
| New patient visit (45+ min) | 51 | $6,056 | $119 |
| Return visit (30+ min) | 55 | $3,173 | $58 |
| Return visit (30+ min) | 30 | $2,780 | $84 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 62 | $2,573 | $41 |
| Long return visit (40+ min) | 12 | $1,280 | $98 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 15 | $1,004 | $67 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 45 | $648 | $14 |
| Ultrasound of heart, follow-up | 32 | $642 | $19 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 45 | $433 | $10 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 34 | $202 | $6 |
| Ultrasound of heart blood flow, valves and chambers | 13 | $186 | $14 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 24 | $107 | $4 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 39 | $99 | $2 |
2021: 19 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 421 | $23,141 | $54 |
| Return visit (30+ min) | 124 | $9,741 | $73 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 33 | $5,699 | $81 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 36 | $5,314 | $56 |
| Long return visit (40+ min) | 34 | $3,908 | $109 |
| Ultrasound of heart with probe in esophagus, with report | 24 | $2,088 | $87 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 20 | $1,525 | $76 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 11 | $1,189 | $108 |
| Hospital discharge day management, 30 minutes or less | 18 | $1,034 | $57 |
| Ultrasound of heart, follow-up | 43 | $853 | $20 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 51 | $814 | $16 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 11 | $617 | $56 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 51 | $551 | $11 |
| Short return visit (20+ min) | 13 | $541 | $42 |
| 3d radiographic procedure with computerized image postprocessing | 12 | $373 | $31 |
| Ultrasound of heart blood flow, valves and chambers | 22 | $318 | $14 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 22 | $220 | $10 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 33 | $192 | $6 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 46 | $115 | $3 |
2020: 19 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 509 | $28,460 | $55 |
| Return visit (30+ min) | 108 | $7,090 | $55 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 52 | $4,793 | $58 |
| Telephone medical discussion with physician, 21-30 minutes | 43 | $2,965 | $63 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 23 | $2,467 | $85 |
| Ultrasound of heart with probe in esophagus, with report | 25 | $2,242 | $86 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 23 | $1,836 | $80 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 11 | $1,239 | $113 |
| Telephone medical discussion with physician, 11-20 minutes | 29 | $1,201 | $40 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 19 | $984 | $52 |
| Hospital discharge day management, 30 minutes or less | 16 | $956 | $60 |
| Ultrasound of heart, follow-up | 40 | $844 | $21 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 51 | $820 | $16 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 16 | $546 | $32 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 50 | $535 | $11 |
| Ultrasound of heart blood flow, valves and chambers | 20 | $315 | $15 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 20 | $212 | $10 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 33 | $186 | $6 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 47 | $122 | $3 |
2019: 19 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 478 | $27,051 | $55 |
| Return visit (30+ min) | 171 | $14,534 | $57 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 46 | $10,138 | $83 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 41 | $4,180 | $102 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 29 | $3,449 | $58 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 21 | $3,382 | $161 |
| New patient visit (45+ min) | 27 | $2,668 | $99 |
| Ultrasound of heart with probe in esophagus, with report | 26 | $2,311 | $86 |
| Long return visit (40+ min) | 24 | $2,053 | $82 |
| Hospital discharge day management, more than 30 minutes | 17 | $1,464 | $86 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 20 | $1,076 | $54 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 60 | $961 | $16 |
| Short return visit (20+ min) | 21 | $769 | $32 |
| Ultrasound of heart, follow-up | 32 | $667 | $21 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 60 | $648 | $11 |
| Ultrasound of heart blood flow, valves and chambers | 23 | $342 | $15 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 24 | $240 | $10 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 33 | $198 | $6 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 52 | $136 | $3 |
2018: 18 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 516 | $27,957 | $53 |
| Return visit (30+ min) | 171 | $16,723 | $56 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 43 | $5,117 | $57 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 39 | $4,070 | $104 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 15 | $2,477 | $83 |
| Long return visit (40+ min) | 23 | $1,870 | $78 |
| New patient visit (45+ min) | 21 | $1,807 | $86 |
| Ultrasound of heart with probe in esophagus, with report | 22 | $1,745 | $76 |
| Hospital discharge day management, more than 30 minutes | 15 | $1,280 | $85 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 67 | $1,095 | $16 |
| Short return visit (20+ min) | 26 | $1,031 | $37 |
| Ultrasound of heart, follow-up | 40 | $799 | $20 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 67 | $731 | $11 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 13 | $562 | $43 |
| Ultrasound of heart blood flow, valves and chambers | 16 | $219 | $14 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 22 | $215 | $9 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 36 | $200 | $6 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 47 | $111 | $2 |
2017: 21 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 503 | $24,548 | $47 |
| Return visit (30+ min) | 150 | $19,969 | $73 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 58 | $6,648 | $56 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 55 | $6,028 | $106 |
| Long return visit (40+ min) | 45 | $5,696 | $105 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 21 | $4,024 | $82 |
| Hospital discharge day management, more than 30 minutes | 38 | $3,301 | $85 |
| New patient visit (45+ min) | 18 | $2,059 | $114 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 291 | $2,010 | $6 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 12 | $1,914 | $159 |
| Ultrasound of heart with probe in esophagus, with report | 23 | $1,650 | $72 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 79 | $1,308 | $17 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 19 | $1,099 | $58 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 79 | $876 | $11 |
| Ultrasound of heart, follow-up | 39 | $783 | $20 |
| Short return visit (20+ min) | 12 | $744 | $57 |
| Routine electrocardiogram (ecg) using at least 12 leads with tracing | 103 | $743 | $6 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 14 | $238 | $14 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 30 | $174 | $6 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 36 | $94 | $3 |
| Insertion of needle into vein for collection of blood sample | 12 | $35 | $3 |
2016: 19 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 449 | $22,238 | $48 |
| Return visit (30+ min) | 130 | $21,497 | $77 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 52 | $7,010 | $56 |
| Long return visit (40+ min) | 55 | $6,925 | $102 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 43 | $4,413 | $103 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 513 | $3,834 | $7 |
| New patient visit (45+ min) | 31 | $3,682 | $119 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 17 | $3,653 | $81 |
| Ultrasound of heart with probe in esophagus, with report | 21 | $2,010 | $91 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 70 | $1,121 | $16 |
| Hospital discharge day management, more than 30 minutes | 14 | $1,004 | $72 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 14 | $901 | $64 |
| Ultrasound of heart, follow-up | 40 | $812 | $20 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 70 | $742 | $11 |
| Short return visit (20+ min) | 12 | $677 | $52 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 32 | $635 | $15 |
| Routine electrocardiogram (ecg) using at least 12 leads with tracing | 54 | $362 | $6 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 22 | $122 | $6 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 31 | $76 | $2 |
2015: 14 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 290 | $13,984 | $47 |
| Return visit (30+ min) | 74 | $12,615 | $83 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 73 | $8,089 | $54 |
| New patient visit (45+ min) | 44 | $5,381 | $122 |
| Short return visit (20+ min) | 56 | $4,481 | $54 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 41 | $4,378 | $104 |
| Long return visit (40+ min) | 27 | $3,025 | $112 |
| Return visit (30+ min) | 14 | $1,104 | $61 |
| Hospital discharge day management, 30 minutes or less | 15 | $799 | $53 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 42 | $730 | $17 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 84 | $595 | $6 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 42 | $480 | $11 |
| Ultrasound of heart, follow-up | 15 | $306 | $20 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 11 | $30 | $3 |
2014: 13 services
| Short return visit (20+ min) | 120 | $10,328 | $49 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 33 | $4,977 | $56 |
| New patient visit (45+ min) | 22 | $2,368 | $108 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 43 | $2,003 | $47 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 42 | $1,650 | $39 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 12 | $1,281 | $107 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 14 | $1,261 | $63 |
| Return visit (30+ min) | 12 | $1,170 | $78 |
| Short return visit | 20 | $728 | $30 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 37 | $420 | $11 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 38 | $260 | $7 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 16 | $252 | $14 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 16 | $172 | $10 |
2013: 13 services
| Short return visit (20+ min) | 146 | $21,016 | $54 |
| New patient visit (45+ min) | 53 | $6,329 | $119 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 84 | $3,551 | $42 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 29 | $2,994 | $68 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring and review and report by health care professional | 15 | $2,444 | $163 |
| Short return visit | 57 | $2,417 | $32 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 72 | $1,328 | $14 |
| Return visit (30+ min) | 14 | $1,179 | $84 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 19 | $867 | $46 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 11 | $615 | $56 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 27 | $423 | $16 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 27 | $282 | $10 |
| Ultrasound of heart, follow-up | 11 | $194 | $18 |
Medicaid work
$6,816 in 2024
Medicaid paid $6,816 for 50 billed services this clinician did in 2024, up to 15 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 35 | $4,477 |
| Long return visit (40+ min) | 15 | $2,339 |
| 2024 | 50 | 2 | 15 | $6,816 |
| 2023 | 171 | 3 | 18 | $18,919 |
| 2022 | 239 | 2 | 53 | $10,529 |
| 2021 | 447 | 2 | 44 | $19,553 |
| 2020 | 471 | 1 | 66 | $20,088 |
| 2019 | 501 | 2 | 51 | $21,343 |
| 2018 | 338 | 1 | 42 | $8,717 |
See the largest Medicaid services in earlier years
2023
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 125 | $13,428 |
| New patient visit (60+ min) | 14 | $2,782 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 32 | $2,709 |
2022
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 201 | $8,251 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 38 | $2,278 |
2021
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 416 | $18,751 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 31 | $802 |
2020
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 471 | $20,088 |
2019
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 488 | $20,551 |
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 13 | $792 |
2018
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 338 | $8,717 |
Drugs they prescribed that Part D paid
$389,409
Pharmacies billed $389,409 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,655) in 2024. At or below the middle of the specialty; the typical cardiology clinician is at 0%.
1,321 generic and 334 brand-name prescriptions · $389,409 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Entresto | 93 | $108,046 | $1,162 |
| Jardiance | 90 | $104,489 | $1,161 |
| Eliquis | 67 | $75,335 | $1,124 |
| Farxiga | 14 | $14,816 | $1,058 |
| Metoprolol | 133 | $2,077 | $16 |
See all 20 drugs
| Entresto | 93 | $108,046 | $1,162 |
| Jardiance | 90 | $104,489 | $1,161 |
| Eliquis | 67 | $75,335 | $1,124 |
| Farxiga | 14 | $14,816 | $1,058 |
| Metoprolol | 133 | $2,077 | $16 |
| Rosuvastatin | 145 | $1,886 | $13 |
| Valsartan | 52 | $1,591 | $31 |
| Atorvastatin | 161 | $1,382 | $9 |
| Ezetimibe | 29 | $1,124 | $39 |
| Spironolactone | 80 | $645 | $8 |
| Diltiazem 24hr Er (Cd) | 18 | $610 | $34 |
| Furosemide | 141 | $523 | $4 |
| Losartan | 72 | $511 | $7 |
| Amlodipine Besylate | 64 | $445 | $7 |
| Carvedilol | 82 | $412 | $5 |
| Potassium Chloride | 32 | $400 | $13 |
| Lisinopril | 34 | $246 | $7 |
| Isosorbide Mononitrate Er | 11 | $196 | $18 |
| Clopidogrel | 22 | $119 | $5 |
| Nitroglycerin | 21 | $77 | $4 |
Year by year
| 2024 | 1,655 | 240 | 0% (0) | 20% | $389,409 |
| 2023 | 1,382 | 225 | None | 19% | $272,028 |
| 2022 | 931 | 169 | 0% (0) | 15% | $135,333 |
| 2021 | 1,205 | 161 | 0% (0) | 17% | $139,520 |
| 2020 | 1,228 | 149 | 0% (0) | 15% | $116,519 |
| 2019 | 1,440 | 160 | None | 15% | $105,756 |
| 2018 | 1,384 | 135 | 0% (0) | 18% | $95,668 |
| 2017 | 1,277 | 126 | 0% (0) | 24% | $99,449 |
| 2016 | 1,019 | 105 | None | 27% | $68,197 |
| 2015 | 585 | 102 | None | 22% | $22,592 |
| 2014 | 1,531 | 134 | 0% (0) | None | $44,869 |
| 2013 | 1,564 | 125 | 0% (0) | None | $34,663 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 21 drugs
| Entresto | 63 | $74,899 | $1,189 |
| Eliquis | 69 | $73,578 | $1,066 |
| Jardiance | 36 | $44,014 | $1,223 |
| Rosuvastatin | 141 | $3,742 | $27 |
| Valsartan | 79 | $3,540 | $45 |
| Metoprolol | 88 | $1,911 | $22 |
| Amiodarone | 15 | $1,351 | $90 |
| Atorvastatin | 102 | $1,204 | $12 |
| Furosemide | 178 | $1,029 | $6 |
| Carvedilol | 32 | $774 | $24 |
| Losartan | 58 | $756 | $13 |
| Spironolactone | 86 | $733 | $9 |
| Bumetanide | 15 | $725 | $48 |
| Potassium Chloride | 21 | $574 | $27 |
| Amlodipine Besylate | 71 | $513 | $7 |
| Isosorbide Mononitrate Er | 15 | $460 | $31 |
| Lisinopril | 29 | $335 | $12 |
| Torsemide | 12 | $279 | $23 |
| Hydralazine | 16 | $212 | $13 |
| Metoprolol | 17 | $75 | $4 |
| Clopidogrel | 11 | $72 | $7 |
2022: 25 drugs
| Eliquis | 71 | $74,124 | $1,044 |
| Entresto | 17 | $19,372 | $1,140 |
| Xarelto | 15 | $11,827 | $788 |
| Rosuvastatin | 69 | $2,767 | $40 |
| Olmesartan Medoxomil | 13 | $1,691 | $130 |
| Amiodarone | 11 | $1,606 | $146 |
| Metoprolol | 54 | $1,572 | $29 |
| Potassium Chloride | 28 | $1,046 | $37 |
| Atorvastatin | 64 | $902 | $14 |
| Ezetimibe | 25 | $896 | $36 |
| Diltiazem 24hr Er (Cd) | 33 | $886 | $27 |
| Furosemide | 68 | $449 | $7 |
| Hydralazine | 15 | $404 | $27 |
| Carvedilol | 37 | $400 | $11 |
| Lisinopril | 43 | $345 | $8 |
| Pravastatin | 19 | $339 | $18 |
| Losartan | 32 | $326 | $10 |
| Amlodipine Besylate | 50 | $314 | $6 |
| Spironolactone | 21 | $285 | $14 |
| Valsartan | 15 | $281 | $19 |
| Pantoprazole | 15 | $259 | $17 |
| Clopidogrel | 20 | $245 | $12 |
| Metoprolol | 23 | $164 | $7 |
| Sotalol | 12 | $122 | $10 |
| Atenolol | 12 | $31 | $3 |
2021: 26 drugs
| Eliquis | 75 | $64,639 | $862 |
| Xarelto | 36 | $27,833 | $773 |
| Repatha Sureclick | 16 | $7,670 | $479 |
| Entresto | 13 | $7,014 | $540 |
| Rosuvastatin | 73 | $2,533 | $35 |
| Metoprolol | 77 | $2,307 | $30 |
| Ezetimibe | 38 | $1,860 | $49 |
| Atorvastatin | 90 | $1,632 | $18 |
| Olmesartan Medoxomil | 20 | $1,625 | $81 |
| Potassium Chloride | 36 | $1,159 | $32 |
| Diltiazem 24hr Er (Cd) | 25 | $1,068 | $43 |
| Pravastatin | 39 | $819 | $21 |
| Losartan | 43 | $700 | $16 |
| Hydralazine | 19 | $668 | $35 |
| Furosemide | 77 | $629 | $8 |
| Lisinopril | 71 | $576 | $8 |
| Carvedilol | 50 | $496 | $10 |
| Amlodipine Besylate | 59 | $449 | $8 |
| Irbesartan | 13 | $379 | $29 |
| Spironolactone | 20 | $368 | $18 |
| Clopidogrel | 21 | $317 | $15 |
| Chlorthalidone | 11 | $262 | $24 |
| Pantoprazole | 18 | $253 | $14 |
| Simvastatin | 13 | $157 | $12 |
| Metoprolol | 37 | $152 | $4 |
| Hydrochlorothiazide | 13 | $147 | $11 |
2020: 25 drugs
| Eliquis | 87 | $70,935 | $815 |
| Xarelto | 22 | $13,719 | $624 |
| Rosuvastatin | 70 | $3,409 | $49 |
| Ezetimibe | 21 | $2,180 | $104 |
| Potassium Chloride | 43 | $1,715 | $40 |
| Metoprolol | 75 | $1,700 | $23 |
| Atorvastatin | 88 | $1,526 | $17 |
| Pravastatin | 54 | $1,267 | $23 |
| Diltiazem 24hr Er (Cd) | 17 | $1,225 | $72 |
| Olmesartan Medoxomil | 22 | $1,033 | $47 |
| Amlodipine Besylate | 86 | $842 | $10 |
| Hydralazine | 22 | $667 | $30 |
| Losartan | 44 | $641 | $15 |
| Lisinopril | 93 | $622 | $7 |
| Carvedilol | 46 | $587 | $13 |
| Furosemide | 81 | $575 | $7 |
| Irbesartan | 13 | $571 | $44 |
| Fenofibrate | 13 | $523 | $40 |
| Clopidogrel | 25 | $505 | $20 |
| Metoprolol | 36 | $300 | $8 |
| Bisoprolol | 19 | $276 | $15 |
| Spironolactone | 24 | $213 | $9 |
| Hydrochlorothiazide | 19 | $198 | $10 |
| Triamterene-Hydrochlorothiazid | 13 | $192 | $15 |
| Benazepril | 12 | $135 | $11 |
2019: 30 drugs
| Eliquis | 63 | $46,470 | $738 |
| Xarelto | 20 | $13,601 | $680 |
| Rosuvastatin | 84 | $5,810 | $69 |
| Livalo | 11 | $5,227 | $475 |
| Ezetimibe | 38 | $3,721 | $98 |
| Bystolic | 11 | $3,252 | $296 |
| Potassium Chloride | 71 | $1,817 | $26 |
| Olmesartan Medoxomil | 22 | $1,716 | $78 |
| Metoprolol | 57 | $1,305 | $23 |
| Atorvastatin | 71 | $925 | $13 |
| Bisoprolol | 42 | $832 | $20 |
| Pravastatin | 52 | $818 | $16 |
| Amlodipine Besylate | 112 | $815 | $7 |
| Losartan | 77 | $810 | $11 |
| Furosemide | 130 | $730 | $6 |
| Lisinopril | 95 | $704 | $7 |
| Fenofibrate | 20 | $667 | $33 |
| Clopidogrel | 33 | $463 | $14 |
| Bumetanide | 11 | $449 | $41 |
| Carvedilol | 47 | $417 | $9 |
| Diltiazem | 11 | $406 | $37 |
| Hydralazine | 26 | $397 | $15 |
| Chlorthalidone | 15 | $331 | $22 |
| Cartia Xt | 11 | $322 | $29 |
| Triamterene-Hydrochlorothiazid | 17 | $229 | $13 |
| Isosorbide Mononitrate Er | 22 | $219 | $10 |
| Metoprolol | 28 | $207 | $7 |
| Hydrochlorothiazide | 18 | $188 | $10 |
| Spironolactone | 18 | $183 | $10 |
| Simvastatin | 16 | $75 | $5 |
2018: 34 drugs
| Eliquis | 77 | $44,717 | $581 |
| Xarelto | 25 | $14,915 | $597 |
| Dofetilide | 11 | $4,520 | $411 |
| Ezetimibe | 29 | $2,349 | $81 |
| Bystolic | 17 | $2,260 | $133 |
| Rosuvastatin | 67 | $2,007 | $30 |
| Diltiazem 12hr Er | 11 | $1,952 | $177 |
| Diltiazem 24hr Er (Cd) | 18 | $1,576 | $88 |
| Potassium Chloride | 43 | $1,292 | $30 |
| Amlodipine Besylate | 127 | $1,113 | $9 |
| Atorvastatin | 96 | $1,064 | $11 |
| Metoprolol | 44 | $1,014 | $23 |
| Warfarin | 18 | $791 | $44 |
| Furosemide | 123 | $750 | $6 |
| Lisinopril | 81 | $648 | $8 |
| Pravastatin | 33 | $617 | $19 |
| Fenofibrate | 21 | $608 | $29 |
| Hydralazine | 42 | $568 | $14 |
| Losartan | 56 | $560 | $10 |
| Clopidogrel | 26 | $411 | $16 |
| Nitroglycerin | 12 | $381 | $32 |
| Fenofibrate | 11 | $374 | $34 |
| Metoprolol | 44 | $308 | $7 |
| Doxazosin Mesylate | 13 | $287 | $22 |
| Chlorthalidone | 14 | $281 | $20 |
| Cartia Xt | 13 | $271 | $21 |
| Isosorbide Mononitrate Er | 29 | $266 | $9 |
| Carvedilol | 37 | $249 | $7 |
| Triamterene-Hydrochlorothiazid | 15 | $184 | $12 |
| Sotalol | 19 | $151 | $8 |
| Spironolactone | 19 | $131 | $7 |
| Clonidine | 16 | $72 | $4 |
| Hydrochlorothiazide | 11 | $66 | $6 |
| Bisoprolol-Hydrochlorothiazide | 11 | $56 | $5 |
2017: 27 drugs
| Eliquis | 71 | $37,955 | $535 |
| Xarelto | 34 | $16,091 | $473 |
| Zetia | 22 | $8,340 | $379 |
| Livalo | 22 | $6,687 | $304 |
| Dofetilide | 16 | $5,635 | $352 |
| Ezetimibe | 24 | $2,764 | $115 |
| Bystolic | 15 | $1,968 | $131 |
| Rosuvastatin | 31 | $1,690 | $55 |
| Metoprolol | 50 | $1,305 | $26 |
| Atorvastatin | 110 | $1,258 | $11 |
| Hydralazine | 43 | $914 | $21 |
| Amlodipine Besylate | 109 | $756 | $7 |
| Potassium Chloride | 22 | $632 | $29 |
| Pravastatin | 29 | $561 | $19 |
| Furosemide | 108 | $551 | $5 |
| Lisinopril | 76 | $496 | $7 |
| Losartan | 69 | $466 | $7 |
| Clopidogrel | 27 | $439 | $16 |
| Amiodarone | 12 | $367 | $31 |
| Cartia Xt | 15 | $358 | $24 |
| Fenofibrate | 21 | $347 | $17 |
| Isosorbide Mononitrate Er | 33 | $298 | $9 |
| Metoprolol | 54 | $260 | $5 |
| Carvedilol | 40 | $232 | $6 |
| Valsartan | 11 | $223 | $20 |
| Spironolactone | 22 | $114 | $5 |
| Levothyroxine | 12 | $66 | $5 |
2016: 20 drugs
| Xarelto | 32 | $14,675 | $459 |
| Zetia | 42 | $12,932 | $308 |
| Eliquis | 28 | $12,215 | $436 |
| Bystolic | 15 | $1,724 | $115 |
| Coumadin | 17 | $1,414 | $83 |
| Atorvastatin | 100 | $1,109 | $11 |
| Hydralazine | 36 | $790 | $22 |
| Pravastatin | 38 | $644 | $17 |
| Isosorbide Mononitrate Er | 63 | $601 | $10 |
| Potassium Chloride | 25 | $460 | $18 |
| Amlodipine Besylate | 72 | $420 | $6 |
| Metoprolol | 20 | $368 | $18 |
| Furosemide | 75 | $344 | $5 |
| Losartan | 78 | $332 | $4 |
| Carvedilol | 33 | $290 | $9 |
| Levothyroxine | 28 | $265 | $9 |
| Metoprolol | 33 | $238 | $7 |
| Lisinopril | 28 | $147 | $5 |
| Clopidogrel | 17 | $101 | $6 |
| Omeprazole | 11 | $59 | $5 |
2015: 13 drugs
| Pravastatin | 35 | $874 | $25 |
| Atorvastatin | 45 | $694 | $15 |
| Potassium Chloride | 18 | $456 | $25 |
| Hydralazine | 20 | $451 | $23 |
| Furosemide | 69 | $287 | $4 |
| Losartan | 30 | $282 | $9 |
| Isosorbide Mononitrate Er | 22 | $269 | $12 |
| Doxazosin Mesylate | 13 | $257 | $20 |
| Amlodipine Besylate | 43 | $243 | $6 |
| Omeprazole | 16 | $193 | $12 |
| Metoprolol | 29 | $178 | $6 |
| Lisinopril | 23 | $131 | $6 |
| Carvedilol | 18 | $128 | $7 |
2014: 35 drugs
| Crestor | 24 | $6,853 | $286 |
| Zetia | 22 | $5,144 | $234 |
| Pradaxa | 12 | $3,015 | $251 |
| Potassium Chloride | 76 | $2,419 | $32 |
| Benicar | 11 | $2,083 | $189 |
| Fenofibrate | 23 | $1,790 | $78 |
| Pravastatin | 47 | $1,317 | $28 |
| Atorvastatin | 92 | $1,283 | $14 |
| Bisoprolol | 33 | $1,206 | $37 |
| Doxazosin Mesylate | 42 | $1,116 | $27 |
| Clopidogrel | 36 | $1,037 | $29 |
| Lisinopril | 135 | $908 | $7 |
| Losartan | 103 | $823 | $8 |
| Amlodipine Besylate | 107 | $679 | $6 |
| Furosemide | 184 | $600 | $3 |
| Escitalopram | 11 | $598 | $54 |
| Klor-Con 10 | 13 | $508 | $39 |
| Carvedilol | 52 | $435 | $8 |
| Diltiazem Er | 11 | $410 | $37 |
| Isosorbide Mononitrate Er | 21 | $397 | $19 |
| Metoprolol | 61 | $382 | $6 |
| Simvastatin | 43 | $343 | $8 |
| Omeprazole | 44 | $278 | $6 |
| Quinapril | 12 | $265 | $22 |
| Verapamil Er | 15 | $252 | $17 |
| Theophylline Anhydrous | 11 | $181 | $16 |
| Hydrochlorothiazide | 15 | $168 | $11 |
| Lovastatin | 15 | $130 | $9 |
| Torsemide | 11 | $129 | $12 |
| Warfarin | 13 | $107 | $8 |
| Amiodarone | 11 | $89 | $8 |
| Diltiazem | 15 | $78 | $5 |
| Spironolactone | 12 | $70 | $6 |
| Clonidine | 12 | $69 | $6 |
| Atenolol | 14 | $53 | $4 |
2013: 30 drugs
| Crestor | 23 | $5,980 | $260 |
| Potassium Chloride | 74 | $2,120 | $29 |
| Atorvastatin | 67 | $1,791 | $27 |
| Bisoprolol | 36 | $1,410 | $39 |
| Lisinopril | 187 | $1,372 | $7 |
| Losartan | 127 | $1,351 | $11 |
| Diltiazem Er | 16 | $934 | $58 |
| Metoprolol | 24 | $923 | $38 |
| Amlodipine Besylate | 115 | $796 | $7 |
| Doxazosin Mesylate | 48 | $726 | $15 |
| Fenofibrate | 17 | $703 | $41 |
| Pravastatin | 38 | $586 | $15 |
| Clopidogrel | 22 | $582 | $26 |
| Furosemide | 136 | $513 | $4 |
| Klor-Con 10 | 12 | $483 | $40 |
| Simvastatin | 58 | $476 | $8 |
| Verapamil Er | 24 | $443 | $18 |
| Metoprolol | 76 | $427 | $6 |
| Isosorbide Mononitrate Er | 23 | $352 | $15 |
| Carvedilol | 31 | $276 | $9 |
| Amiodarone | 11 | $276 | $25 |
| Quinapril | 11 | $243 | $22 |
| Warfarin | 35 | $231 | $7 |
| Hydrochlorothiazide | 38 | $217 | $6 |
| Losartan-Hydrochlorothiazide | 17 | $168 | $10 |
| Clonidine | 24 | $153 | $6 |
| Bumetanide | 15 | $106 | $7 |
| Diltiazem | 16 | $79 | $5 |
| Spironolactone | 12 | $75 | $6 |
| Atenolol | 14 | $52 | $4 |
Money from drug and device companies
$52 in 2025
A payment is not proof that care is biased.
| Vanda Pharmaceuticals | Fanapt | $29 | 1 payment
|
| Pfizer | Vyndaqel | $23 | 1 payment
|
See all 2 published payments
| Pfizer | Meals · 2025-05-14 | Vyndaqel | $23 |
| Vanda Pharmaceuticals | Meals · 2025-01-17 | Fanapt | $29 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 74.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1740288901
- Licence
- CA C180793California C180793: Current · expires 2028-09-30
- Group
- UCSF Medical Group Business Services · Regents of the University of California · University of California San Francisco
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Cardiology (207RC0000X)
- Mailing address
- 505 Parnassus Ave # 124, San Francisco, CA, 94143
- NPI first listed
- 2005-07-12
- NPI last updated
- 2022-08-11
- NPI record certified
- 2022-08-09
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 505 Parnassus Ave, San Francisco, CA, 94143